Management are on the ball here.
Excellent management.
Next year is looking great!!!!
"On 12 December 2016 the Company issued the following securities under a rights issue prospectus: (i) 22,929,870 Shares at 5 cents per Share to raise $1,146,493 being a discount to the then market price of 5.3 cents. $950,306 has been spent to date on advancing its key anti-cancer product, Monepantel towards the clinic and general working capital. $196,187 remains to be used on the Company's projects and general working capital; and (ii) 7,643,353 free attaching unlisted Options with an exercise price of 12 cents and an expiry date of 30 November 2019. The current value of the Options is 1.5 cents per Option in accordance with a Black and Scholes valuation. On 30 December 2016 the Company issued the following securities under a Page 13 rights issue prospectus: (iii) 31,261,388 Shares at 5 cents per Share to raise $1,563,069 being a discount to the then market price of 5.8 cents. None of these moneys have been spent to date and $1,563,069 remains to be used on the Company's projects and general working capital; and (iv) 10,420,499 free attaching unlisted Options with an exercise price of 12 cents and an expiry date of 30 November 2019. The current value of the Options is 1.5 cents per Option in accordance with a Black and Scholes valuation. On 3 March 2017 the Company issued the following securities under a rights issue prospectus: (v) 10,674,650 Shares at 5 cents per Share to raise $533,732 being no discount to the then market price of 5 cents. None of these moneys have been spent to date and $533,732 remains to be used on the Company's projects and general working capital; and (vi) 3,558,226 free attaching unlisted Options with an exercise price of 12 cents and an expiry date of 30 November 2019. The current value of the Options is 1.5 cents per Option in accordance with a Black and Scholes valuation."
This is tight money control and we are defiantly getting value added here.
WE are well in front!!
Notice of coarse that the burn rate is about 300K per quarter, NOT A MILLION!!!!
My bet is next quarter will see a surplus................
As always,
Best
MM
- Forums
- ASX - By Stock
- NUZ
- Ann: Notice of Annual General Meeting/Proxy Form
Ann: Notice of Annual General Meeting/Proxy Form, page-2
-
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NUZ (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.3¢ |
Change
-0.008(3.75%) |
Mkt cap ! $95.88M |
Open | High | Low | Value | Volume |
20.0¢ | 20.5¢ | 19.0¢ | $55.74K | 284.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 148036 | 19.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.5¢ | 63645 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 148036 | 0.190 |
11 | 720520 | 0.185 |
8 | 384080 | 0.180 |
5 | 151797 | 0.175 |
7 | 208030 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.195 | 63645 | 3 |
0.200 | 27861 | 2 |
0.205 | 101607 | 5 |
0.210 | 148876 | 3 |
0.215 | 154400 | 2 |
Last trade - 13.50pm 18/11/2024 (20 minute delay) ? |
Featured News
NUZ (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online